Home
About
Product
magNews
Career
Contact Us
中文
English
Corporate
Corporate
Industry
Technology
Medical Updates
Corporate
magAssist Once Again Named in 2023 Future Healthcare VB100 List- China Innovative Medical Devices List
2023-05-09
Corporate
magAssist Forges University-Enterprise Cooperation with Domestic and International Universities to Empower Innovative Talents Cultivation Scheme
2023-01-12
Corporate
Dr. Po-Lin Hsu Named on List of Forbes China - 100 Outstanding Overseas Returnees
2022-12-14
Corporate
magAssist is on the list of Forbes Asia 100 to Watch 2022
2022-09-09
Corporate
First Patient with NyokAssist™ Interventional Ventricular Assist Device: Dr. Junbo Ge's team successfully completed the first high-risk PCI treatment supported by the new generation of interventi
2023-09-05
Corporate
magAssist ECMO approved in the Transformation of Scientific and Technological Achievements Special Fund
2023-08-28
Corporate
Successful Completion of Clinical Trial for MoyoAssist® Extra-VAD Fully Maglev Artificial Heart Independently Developed in China
2023-08-21
Corporate
magAssist's NyokAssist™️ granted Designation by the FDA as a Breakthrough Device
2023-08-17
Corporate
The Cross-Strait Youth Cultural Month Kicks off, as magAssist Engages in a Dialogue with Taiwanese Youth
2023-07-28
Corporate
BreathMo®: The New Generation ECMO system Revealed at ASAIO Conference
2023-07-22
Corporate
MoyoAssist® Extra-VAD, a Promising Solution for Short-to-Medium-Term Ventricular Assist for China NMPA trial, Showcased at 4th Academic Annual Conference of CSBE
2023-06-17
Corporate
Embarking on an Innovation Journey with Students from Duke Kunshan University
2023-06-13
Corporate
magAssist Among Exclusive 17 Selected Enterprises in Suzhou
2023-05-29
Corporate
magAssist Once Again Named in 2023 Future Healthcare VB100 List- China Innovative Medical Devices List
2023-05-09
1
2
3
4
5
···
1/6
》
Tags:
HRPCI,
Ventricular Assist Device,
NyokAssist,
FDA,
Breakthrough Device,
Conference,
ASAIO,
Medical device,
ECMO,
Cardiac treatment,
TOP